Therapeutic Advances in Gastroenterology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：审稿挺快的，第一次审稿一个多月给意见，两个审稿人，其中一个提了30多条意见，从写作，到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后，接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=)]

2024-10-06 zkfy 来自山东省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验

61 0

[GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：审稿挺快的，第一次审稿一个多月给意见，两个审稿人，其中一个提了30多条意见，从写作，到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后，接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=)]

2024-08-16 ms9000000883043898 来自湖南省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：不容易

46 0

[GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：审稿挺快的，第一次审稿一个多月给意见，两个审稿人，其中一个提了30多条意见，从写作，到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后，接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=)]

2024-04-11 烂医生来自北京

偏重的研究方向：炎症性肠病
经验分享：20天还是submitted，垃圾

94 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：审稿挺快的，第一次审稿一个多月给意见，两个审稿人，其中一个提了30多条意见，从写作，到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后，接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=)]

2023-11-10 ms5000001527012845 来自上海

一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！

106 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：审稿挺快的，第一次审稿一个多月给意见，两个审稿人，其中一个提了30多条意见，从写作，到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后，接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=)]

2021-12-27 学医的彭于晏

同一杂志社不同期刊如何转投（transfer）？

174 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：审稿挺快的，第一次审稿一个多月给意见，两个审稿人，其中一个提了30多条意见，从写作，到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后，接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=)]

2023-11-06 ms59932566 来自上海

审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。

132 0

[GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：审稿挺快的，第一次审稿一个多月给意见，两个审稿人，其中一个提了30多条意见，从写作，到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后，接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=)]

2023-11-02 MS54111233 来自上海

3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！

105 0

[GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：审稿挺快的，第一次审稿一个多月给意见，两个审稿人，其中一个提了30多条意见，从写作，到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后，接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=)]

2023-10-17 ms5000001464638126 来自广东省

审稿速度:1.0 | 投稿命中率:50.0
经验分享：一般

113 0

[GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：审稿挺快的，第一次审稿一个多月给意见，两个审稿人，其中一个提了30多条意见，从写作，到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后，接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=)]

2022-11-05 ms8000000798079608

偏重的研究方向：肿瘤
经验分享：请问大家这个杂志不收基础研究吗

148 0

[GetPortalCommentsPageByObjectIdResponse(id=2229484, encodeId=e97c22294843c, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3月份投稿，6月份大修，按照大修意见修改后再次重新送外审，9月回来编辑意见，直接拒稿，感觉很垃圾，很耽误时间，很差的体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83errJKiaqSUBvFIkVib9xiaefC5ufjgicicZXFOJQmCBUEbuWaQ5ia3EOYJA0dCTSSicSGvfHthlPHQ458P7w/132, createdBy=ea485305359, createdName=zkfy, createdTime=Sun Oct 06 09:40:54 CST 2024, time=2024-10-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2220369, encodeId=7e4322203695c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8836559826, createdName=ms9000000883043898, createdTime=Fri Aug 16 00:31:10 CST 2024, time=2024-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2197976, encodeId=7d70219e97639, content=偏重的研究方向：炎症性肠病 经验分享：20天还是submitted，垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/c8f4595dadea4266aa1532bb03641b54/0826761e11894dafafe181f2cae69424.jpg, createdBy=1b7c5246256, createdName=烂医生, createdTime=Thu Apr 11 14:22:01 CST 2024, time=2024-04-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167787, encodeId=664c216e787df, content=一审一个月，论文得到了审稿专家的认可和肯定，给出的修回意见也很中肯，二审一个月，秒接收！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037e6160919, createdName=ms5000001527012845, createdTime=Fri Nov 10 10:51:16 CST 2023, time=2023-11-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105608, encodeId=abfa110560886, content=同一杂志社不同期刊如何转投（transfer）？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167000, encodeId=1873216e000af, content=审稿时间一个月，给了一个月时间大修。修改意见很详实不刁钻，看得出审稿人还是挺有水平的。赶了一个月实验后投出去。两个星期后就被接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf526407066, createdName=ms59932566, createdTime=Mon Nov 06 14:06:24 CST 2023, time=2023-11-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2166328, encodeId=0bf52166328b6, content=3月提交，4月中返修。评审给了比较多的意见，感觉是比较严苛的，但也很受用。大修6月提交，7月就收到了接收回复，赞！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54111233, createdTime=Thu Nov 02 17:36:17 CST 2023, time=2023-11-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2163260, encodeId=6db22163260a2, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42aa6480365, createdName=ms5000001464638126, createdTime=Tue Oct 17 11:09:26 CST 2023, time=2023-10-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098730, encodeId=c2982098e30e7, content=偏重的研究方向：肿瘤 经验分享：请问大家这个杂志不收基础研究吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Nov 05 19:44:12 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892149, encodeId=9fbd89214975, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：炎症性肠病 经验分享：审稿挺快的，第一次审稿一个多月给意见，两个审稿人，其中一个提了30多条意见，从写作，到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后，接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/08/1443c7a69fef248e40b457447f46c13e.jpg, createdBy=5b121939878, createdName=最后一根火柴, createdTime=Wed Oct 14 23:30:47 CST 2020, time=2020-10-14, status=1, ipAttribution=)]

2020-10-14 最后一根火柴

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：炎症性肠病
经验分享：审稿挺快的，第一次审稿一个多月给意见，两个审稿人，其中一个提了30多条意见，从写作，到分析等非常详细。给了个大修。另一个审稿人提的意见少一些。第二次审稿半个多月后，接收了。

243 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务